Puma Biotechnology (PBYI) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Puma Biotechnology (PBYI) over the last 6 years, with Sep 2025 value amounting to $0.17.
- Puma Biotechnology's EPS (Weighted Average and Diluted) fell 58.54% to $0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 59.57%. This contributed to the annual value of $0.62 for FY2024, which is 37.78% up from last year.
- As of Q3 2025, Puma Biotechnology's EPS (Weighted Average and Diluted) stood at $0.17, which was up 41.67% from $0.12 recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) registered a high of $0.41 during Q3 2024, and its lowest value of -$1.09 during Q3 2021.
- Over the past 3 years, Puma Biotechnology's median EPS (Weighted Average and Diluted) value was $0.12 (recorded in 2025), while the average stood at $0.13.
- In the last 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) skyrocketed by 1,300.00% in 2023 and then slumped by 433.33% in 2024.
- Over the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) (Quarterly) stood at $0.10 in 2021, then plummeted by 230.00% to -$0.13 in 2022, then surged by 292.31% to $0.25 in 2023, then surged by 60.00% to $0.40 in 2024, then slumped by 58.54% to $0.17 in 2025.
- Its last three reported values are $0.17 in Q3 2025, $0.12 for Q2 2025, and $0.06 during Q1 2025.